AIP
KRRO icon

Ameritas Investment Partners’s Korro Bio KRRO Stock Holding History

Ameritas Investment Partners’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.77K Hold
598
– – ﹤0.01% 2940
2025
Q4 		$4.79K Hold
598
– – ﹤0.01% 3035
2025
Q3 		$28.6K Hold
598
– – ﹤0.01% 2505
2025
Q2 		$7.47K Hold
598
– – ﹤0.01% 3046
2025
Q1 		$10.4K Hold
598
– – ﹤0.01% 2809
2024
Q4 		$22.8K Hold
598
– – ﹤0.01% 2575
2024
Q3 		$20K Hold
598
– – ﹤0.01% 2656
2024
Q2 		$20.3K Buy
+598
New +$33K ﹤0.01% 2606
2022
Q2 		– Sell
-43
Closed -$5K – 3156
2022
Q1 		$5K Hold
43
– – ﹤0.01% 2968
2021
Q4 		$11K Hold
43
– – ﹤0.01% 2868
2021
Q3 		$15K Hold
43
– – ﹤0.01% 2820
2021
Q2 		$21K Hold
43
– – ﹤0.01% 2709
2021
Q1 		$20K Hold
43
– – ﹤0.01% 2560
2020
Q4 		$75K Hold
43
– – ﹤0.01% 1732
2020
Q3 		$41K Sell
43
-7
-14% -$7.51K ﹤0.01% 1956
2020
Q2 		$58K Buy
50
+40
+400% +$36.1K ﹤0.01% 1741
2020
Q1 		$9K Hold
10
– – ﹤0.01% 2600
2019
Q4 		$9K Buy
+10
New +$7.78K ﹤0.01% 2774

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Ameritas Investment Partners's KRRO Position: Q1 2026 in Review

Ameritas Investment Partners held its Korro Bio (KRRO) position steady in Q1 2026 at 598 shares worth $6.77K. The position accounts for ﹤0.01% of the portfolio, ranked #2940.

Ameritas Investment Partners first reported a position in KRRO in Q4 2019 and has held it in 18 quarters since. The position peaked at $75K in Q4 2020. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Ameritas Investment Partners held 598 shares of Korro Bio worth $6.77K as of Q1 2026.
  • Ameritas Investment Partners left its Korro Bio share count unchanged in Q1 2026.
  • Korro Bio made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2940 holding.
  • Ameritas Investment Partners first reported a position in Korro Bio in Q4 2019 and has held it in 18 quarters since.
  • Ameritas Investment Partners's Korro Bio position peaked at $75K in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.